aap Implantate AG

Share Issue/Capital Change • Sep 2, 2008

News Details

Ad-hoc | 2 September 2008 12:08

aap Implantate AG plans 5% Capital Increase

aap Implantate AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

The Management Board of aap Implantate AG, a medical technology company
listed on the Frankfurt stock exchange in the Prime Standard segment,
decided today with the Supervisory Board’s approval to increase its capital
stock from authorized capital by up to 5%, or up to €1,267,357. The new
shares are to be offered to interested investors, excluding a rights
entitlement for existing shareholders, by way of an accelerated private
placement in return for a cash contribution at a price close to the present
market price. A public offering will not take place. The transaction is to
be implemented at short notice subject to the market situation.

The inflow of funds from the capital increase is to serve the purpose of
funding further growth. A further aim is to widen the institutional
shareholder base by means of the placement.

Contact:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Investor & Public Relations; Lorenzweg
5; D-12099 Berlin
Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; n.huedepohl@aap.de

02.09.2008 Financial News transmitted by DGAP

Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: aap@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service

---